Ali Azarbarzin1, Scott A Sands1, Katie L Stone2,3, Luigi Taranto-Montemurro1, Ludovico Messineo1, Philip I Terrill4, Sonia Ancoli-Israel5,6, Kristine Ensrud7, Shaun Purcell1,8, David P White1, Susan Redline1, Andrew Wellman1. 1. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Sleep Disordered Breathing Lab, 221 Longwood Avenue, Boston, MA, USA. 2. Research Institute, California Pacific Medical Center, 550 16th Street, 2nd Floor, San Francisco, CA, USA. 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, 550 16th St, San Francisco, CA, USA. 4. School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Australia. 5. Department of Psychiatry, University of California San Diego, 9500 Gilman Drive La Jolla, CA, USA. 6. Department of Medicine, University of California San Diego, 9500 Gilman Drive La Jolla, CA, USA. 7. University of Minnesota and Minneapolis Veterans Affairs Health Care System, 1 Veterans Dr, Minneapolis, MN, USA. 8. Stanley Center for Psychiatric Research, Broad Institute of MIT & Harvard, 415 Main St, Cambridge, MA, USA.
Abstract
AIMS: Apnoea-hypopnoea index (AHI), the universal clinical metric of sleep apnoea severity, poorly predicts the adverse outcomes of sleep apnoea, potentially because the AHI, a frequency measure, does not adequately capture disease burden. Therefore, we sought to evaluate whether quantifying the severity of sleep apnoea by the 'hypoxic burden' would predict mortality among adults aged 40 and older. METHODS AND RESULTS: The samples were derived from two cohort studies: The Outcomes of Sleep Disorders in Older Men (MrOS), which included 2743 men, age 76.3 ± 5.5 years; and the Sleep Heart Health Study (SHHS), which included 5111 middle-aged and older adults (52.8% women), age: 63.7 ± 10.9 years. The outcomes were all-cause and Cardiovascular disease (CVD)-related mortality. The hypoxic burden was determined by measuring the respiratory event-associated area under the desaturation curve from pre-event baseline. Cox models were used to calculate the adjusted hazard ratios for hypoxic burden. Unlike the AHI, the hypoxic burden strongly predicted CVD mortality and all-cause mortality (only in MrOS). Individuals in the MrOS study with hypoxic burden in the highest two quintiles had hazard ratios of 1.81 [95% confidence interval (CI) 1.25-2.62] and 2.73 (95% CI 1.71-4.36), respectively. Similarly, the group in the SHHS with hypoxic burden in the highest quintile had a hazard ratio of 1.96 (95% CI 1.11-3.43). CONCLUSION: The 'hypoxic burden', an easily derived signal from overnight sleep study, predicts CVD mortality across populations. The findings suggest that not only the frequency but the depth and duration of sleep related upper airway obstructions, are important disease characterizing features. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Apnoea-hypopnoea index (AHI), the universal clinical metric of sleep apnoea severity, poorly predicts the adverse outcomes of sleep apnoea, potentially because the AHI, a frequency measure, does not adequately capture disease burden. Therefore, we sought to evaluate whether quantifying the severity of sleep apnoea by the 'hypoxic burden' would predict mortality among adults aged 40 and older. METHODS AND RESULTS: The samples were derived from two cohort studies: The Outcomes of Sleep Disorders in Older Men (MrOS), which included 2743 men, age 76.3 ± 5.5 years; and the Sleep Heart Health Study (SHHS), which included 5111 middle-aged and older adults (52.8% women), age: 63.7 ± 10.9 years. The outcomes were all-cause and Cardiovascular disease (CVD)-related mortality. The hypoxic burden was determined by measuring the respiratory event-associated area under the desaturation curve from pre-event baseline. Cox models were used to calculate the adjusted hazard ratios for hypoxic burden. Unlike the AHI, the hypoxic burden strongly predicted CVDmortality and all-cause mortality (only in MrOS). Individuals in the MrOS study with hypoxic burden in the highest two quintiles had hazard ratios of 1.81 [95% confidence interval (CI) 1.25-2.62] and 2.73 (95% CI 1.71-4.36), respectively. Similarly, the group in the SHHS with hypoxic burden in the highest quintile had a hazard ratio of 1.96 (95% CI 1.11-3.43). CONCLUSION: The 'hypoxic burden', an easily derived signal from overnight sleep study, predicts CVDmortality across populations. The findings suggest that not only the frequency but the depth and duration of sleep related upper airway obstructions, are important disease characterizing features. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: S Redline; M H Sanders; B K Lind; S F Quan; C Iber; D J Gottlieb; W H Bonekat; D M Rapoport; P L Smith; J P Kiley Journal: Sleep Date: 1998-11-01 Impact factor: 5.849
Authors: Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson Journal: Am J Respir Crit Care Med Date: 2002-07-15 Impact factor: 21.405
Authors: F J Nieto; T B Young; B K Lind; E Shahar; J M Samet; S Redline; R B D'Agostino; A B Newman; M D Lebowitz; T G Pickering Journal: JAMA Date: 2000-04-12 Impact factor: 56.272
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: Kelsie M Full; Chandra L Jackson; Casey M Rebholz; Kunihiro Matsushita; Pamela L Lutsey Journal: J Am Soc Nephrol Date: 2020-06-26 Impact factor: 10.121
Authors: Luigi Taranto-Montemurro; Ludovico Messineo; Scott A Sands; Ali Azarbarzin; Melania Marques; Bradley A Edwards; Danny J Eckert; David P White; Andrew Wellman Journal: Am J Respir Crit Care Med Date: 2019-05-15 Impact factor: 21.405
Authors: Dominik Linz; Kelly A Loffler; Prashanthan Sanders; Peter Catcheside; Craig S Anderson; Danni Zheng; WeiWei Quan; Mary Barnes; Susan Redline; R Doug McEvoy; Mathias Baumert Journal: Chest Date: 2020-07-14 Impact factor: 9.410
Authors: Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel Journal: Sleep Med Rev Date: 2020-03-20 Impact factor: 11.609
Authors: Ali Azarbarzin; Scott A Sands; Luigi Taranto-Montemurro; Daniel Vena; Tamar Sofer; Sang-Wook Kim; Katie L Stone; David P White; Andrew Wellman; Susan Redline Journal: Chest Date: 2020-04-13 Impact factor: 9.410